Medtronic reported FY2025 revenue of $33.54 billion and fiscal Q3 2026 revenue of $9.02 billion, keeping the thesis on whether device innovation can translate into durable margins, cash flow and balance-sheet discipline.
References
Sources used in this report
SEC datasetSEC company tickers exchange dataset2026-05-20 · Primary evidence for issuer identity, exchange, ticker and CIK.SEC APISEC submissions API2026-05-20 · Primary evidence for filing chronology and latest forms.SEC APISEC companyfacts API2026-05-20 · Primary evidence for financial statement facts used in the article and deck.SEC filingForm 10-K2025-06-20 · Annual business, risk and financial statement baseline.SEC filingForm 10-Q2026-02-24 · Latest interim financial statement baseline.SEC filingForm 8-K2026-05-18 · Recent event chronology.SEC filingDEF 14A2025-08-25 · Governance, meeting and incentive baseline.